Methylation Diet and Lifestyle Study

Exclusion Criteria

• •• Currently taking any of the following prescription medications
• •* Proton pump inhibitors: omeprazole (Prilosec, Prilosec OTC); aspirin and omeprazole (Yosprala); lansoprazole (Prevacid, Prevacid IV, Prevacid 24-Hour); ;dexlansoprazole (Dexilent, Dexilent Solutab); rabeprazole (Aciphex, Aciphex Sprinkle); pantoprazole (Protonix)
• •* H2-blockers: nizatidine (Axid, Axid AR, Axid Pulvules); famotidine (Pepcid, Pepcid AC); cimetidine (Tagamet, Tagamet HB); ranitidine (Zantac)
• •* These classes of medications are excluded due to direct (due to nutrient requirements for metabolism) and indirect (through impaired digestion and assimilation of nutrients).
• •* Use of nutrition supplements or herbal products not prescribed by a licensed healthcare provider for a medical condition
• •* Currently following a prescribed dietary/lifestyle program or initiate within the 30 days prior to baseline
• •* Initiation of or changes to an exercise regimen within 30 days prior to baseline
• •* Use of nicotine, marijuana or cannabinoids (including CBD products) or recreational drugs/substances (such as but not limited to cocaine, phencyclidine \[PCP\], and methamphetamine) current/within the last 30 days or use during the study
• •* Have a diagnosis of cardiovascular disease, kidney disease, liver disease, diabetes, autoimmune disease, high blood pressure, or cancer (does not include basal cell carcinoma, squamous cell carcinoma, and/or carcinoma in situ of the cervix).
• •* Have a diagnosis of an immunodeficiency condition, such as Human Immunodeficiency Virus (HIV) infection or Acquired Immune Deficiency Syndrome (AIDS)
• •* Have a diagnosis of neurodegenerative conditions such as, amyotrophic lateral sclerosis (ALS), Parkinson's disease, Multiple Sclerosis, or Alzheimer's disease.
• •* Excessive alcohol consumption (more than 4 drinks per day or 14 per week on average)
• •* Known sensitivity, intolerance or allergy to ingredients in the study supplements or in the recommended dietary therapy
• •* Currently receiving intravenous nutrient therapy
• •* Currently participating in another interventional research study or participated in another interventional study within the last 3 weeks prior to baseline